ABBV Jun 2022 95.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:21AM EDT. Market open.
| Previous close | 0.0700 |
| Open | 0.0700 |
| Bid | 0.0200 |
| Ask | 0.2200 |
| Strike | 95.00 |
| Expiry date | 2022-06-17 |
| Day's range | 0.0700 - 0.0700 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.33k |
- Editor's pickYahoo Finance Video
Buffett’s Berkshire Hathaway is buying up Chevron, Citigroup, Paramount stocks
Yahoo Finance's Jared Blikre breaks down the stocks Warren Buffett's Berkshire Hathaway is buying and selling.
- Motley Fool
Is It Too Late to Buy AbbVie Stock?
Pharma giant AbbVie (NYSE: ABBV) has rewarded shareholders in the past decade with market-beating performance. AbbVie's strong showing was primarily a result of its top-selling drug, Humira. If the company manages to replace the medicine, it could deliver many more years of solid performances.
- Zacks
AbbVie (ABBV) Buys Option Rights to NextGen Inflammation Drug
AbbVie (ABBV) receives the option to license worldwide rights for certain IL-2 muteins, including the next-generation inflammatory candidate, CUG252 from Cugene
© 2022 Yahoo. All rights reserved.
